The 3 Most Promising Big Pharma Dividends for the Next 5 Years

Few industries provide the same kind of dividend power as big pharma. Between top-selling drugs, cash-cow medications, and up-and-coming blockbusters, pharmaceutical companies like Pfizer (NYSE: PFE  ) and Johnson & Johnson (NYSE: JNJ  ) boast the financial fortitude and portfolio firepower to provide for dividend investors for years to come.

Yet in an industry as competitive as this, which are the best stocks for dividend investors to target? Johnson & Johnson's breadth has provided a strong, stable base for dividend investors for the long term, but with the company's medical device business slowing, is this stock slumping out of the top segment of health care stocks?

Not to worry, Johnson & Johnson investors. In the video below, Fool contributor Dan Carroll shows you three big pharma stocks -- including J&J -- that have the potential to transform portfolios in the long run and deliver the types of dividends that will reward investors handsomely for years to come.

The best way to win with your dividend stock picks
Pfizer and Johnson & Johnson are two of health care's top names and members of the Dow Jones, but are they the best blue-chip dividend stocks for your money? If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.


Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2728172, ~/Articles/ArticleHandler.aspx, 10/22/2014 6:10:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement